ERF772 - HOSPITAL APPLICATION of RADIOPHARMACEUTICALS
| Course Name | Code | Semester | Theory (hours/week) |
Application (hours/week) |
Credit | ECTS |
|---|---|---|---|---|---|---|
| HOSPITAL APPLICATION of RADIOPHARMACEUTICALS | ERF772 | 1st Semester | 2 | 4 | 4 | 10 |
| Prequisites | ||||||
| Course language | Turkish | |||||
| Course type | Elective | |||||
| Mode of Delivery | Face-to-Face | |||||
| Learning and teaching strategies | Lecture Discussion | |||||
| Instructor (s) | Prof.Dr. Suna Erdoğan, Assist.Prof.Dr. Mine Silindir Günay, Prof.Dr. Belkıs Erbaş, Prof.Dr. Murat Tuncel, Prof.Dr. M. Fani Bozkurt, Assoc.Prof.Dr. Bilge Volkan Salancı | |||||
| Course objective | The aim of this course is to teach the clinical use of radiopharmaceuticals used for either diagnosis or therapy and provide solution for possible problems met during the practice. | |||||
| Learning outcomes |
| |||||
| Course Content | - Radiopharmaceuticals currently used in clinic, their preparation and their application - Radiopharmaceuticals used in heart imaging; case evaluation by radiopharmacist and nuclear medicine doctor - Radiopharmaceuticals used in bone imaging; case evaluation - Radiopharmaceuticals used in thyroid imaging; case evaluation - Radiopharmaceuticals used in kidney imaging; case evaluation - Radiopharmaceuticals used in brain imaging; case evaluation - Radiopharmaceuticals used in respiratory system imaging; case evaluation - Radiopharmaceuticals used in oncology; case evaluation - Radiopharmaceuticals used for pediatric application; case evaluation - Radiopharmaceuticals used for therapy; case evaluation | |||||
| References | - CB Sampson Textbook of Radiopharmacy; Theory and Practice, 1994. - SK Niazi, Handbook of Pharmaceutical Manufacturing Formulatins: Sterile Products, Vol 6, 2009. - GM Pomper, JG Gelovani, Molecular Imaging in Oncology, 2008. - S Vallabhajosula, Molecular Imaging, Radiopharmaceuticals for PET and SPECT, 2009. | |||||
Course outline weekly
| Weeks | Topics |
|---|---|
| Week 1 | Introduction |
| Week 2 | Radiopharmaceuticals currently used in clinic, their preparation and their application |
| Week 3 | Radiopharmaceuticals used in heart imaging, case evaluation by radiopharmacist and nuclear medicine doctor |
| Week 4 | Radiopharmaceuticals used in bone imaging, case evaluation by radiopharmacist and nuclear medicine doctor |
| Week 5 | Radiopharmaceuticals used in bone imaging, case evaluation by radiopharmacist and nuclear medicine doctor (cont.) |
| Week 6 | Radiopharmaceuticals used in thyroid imaging, case evaluation by radiopharmacist and nuclear medicine doctor |
| Week 7 | Radiopharmaceuticals used in kidney imaging, case evaluation by radiopharmacist and nuclear medicine doctor |
| Week 8 | Radiopharmaceuticals used in brain imaging, case evaluation by radiopharmacist and nuclear medicine doctor |
| Week 9 | Radiopharmaceuticals used in respiratory system imaging, case evaluation by radiopharmacist and nuclear medicine doctor |
| Week 10 | Radiopharmaceuticals used in oncology, case evaluation by radiopharmacist and nuclear medicine doctor |
| Week 11 | Radiopharmaceuticals used in oncology, case evaluation by radiopharmacist and nuclear medicine doctor (cont.) |
| Week 12 | Radiopharmaceuticals used for pediatric application, case evaluation by radiopharmacist and nuclear medicine doctor |
| Week 13 | Radiopharmaceuticals used for therapy, case evaluation by radiopharmacist and nuclear medicine doctor |
| Week 14 | Radiopharmaceuticals used for therapy, case evaluation by radiopharmacist and nuclear medicine doctor (cont) |
| Week 15 | Preparation for final exam |
| Week 16 | Final exam |
Assesment methods
| Course activities | Number | Percentage |
|---|---|---|
| Attendance | 0 | 0 |
| Laboratory | 0 | 0 |
| Application | 0 | 0 |
| Field activities | 0 | 0 |
| Specific practical training | 0 | 0 |
| Assignments | 0 | 0 |
| Presentation | 0 | 0 |
| Project | 0 | 0 |
| Seminar | 0 | 0 |
| Midterms | 1 | 50 |
| Final exam | 1 | 50 |
| Total | 100 | |
| Percentage of semester activities contributing grade succes | 1 | 50 |
| Percentage of final exam contributing grade succes | 1 | 50 |
| Total | 100 | |
WORKLOAD AND ECTS CALCULATION
| Activities | Number | Duration (hour) | Total Work Load |
|---|---|---|---|
| Course Duration (x14) | 14 | 2 | 28 |
| Laboratory | 0 | 0 | 0 |
| Application | 14 | 4 | 56 |
| Specific practical training | 0 | 0 | 0 |
| Field activities | 0 | 0 | 0 |
| Study Hours Out of Class (Preliminary work, reinforcement, ect) | 14 | 6 | 84 |
| Presentation / Seminar Preparation | 0 | 0 | 0 |
| Project | 0 | 0 | 0 |
| Homework assignment | 0 | 0 | 0 |
| Midterms (Study duration) | 1 | 62 | 62 |
| Final Exam (Study duration) | 1 | 90 | 90 |
| Total Workload | 44 | 164 | 320 |
Matrix Of The Course Learning Outcomes Versus Program Outcomes
| D.9. Key Learning Outcomes | Contrubition level* | ||||
|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | |
| 1. Know the biological effects of radiation and principles of radiation protection. | X | ||||
| 2. Know radioactive substances and their properties. Uses this information in the development of new radiopharmaceuticals. | X | ||||
| 3. Know the biodistribution of radiopharmaceuticals after administration to the body, the factor that may alter the biodistribution, their localization and uptake mechanism into cells, mechanisms of action, undesirable effects, and interactions with drugs. | X | ||||
| 4. Design a new radiopharmaceutical, plans and carries out studies on its formulation, production, stability and quality assurance. Use the field-specific devices effectively during studies. | X | ||||
| 5. Know the effect of the radiation on pharmaceutics, cosmetics, active ingredients, drug delivery systems, and medical devices. Know how to control/prevent the probable variations. | X | ||||
| 6. Improve a novel idea, method, design and/or application in the field of Radiopharmacy or apply a known idea, method, design and/or application in that field or in a different field. | X | ||||
| 7. Perform a research/experimental design using current resources and perform a study, analyze the data, annotate the results. Publish the results in a national/international journal and share in scientific meetings. | X | ||||
| 8. Integrate and improve the theoretical and practical knowledge with the knowledge from different disciplines. | X | ||||
| 9. Perform the studies in the frame of ethical principles. | X | ||||
*1 Lowest, 2 Low, 3 Average, 4 High, 5 Highest